18
1 Pharma/biotech v. Technology Patent Search and Analysis PIUG 2014 Annual Conference Dilip P. Pandya Manager, Research & Analysis, Qualcomm Library & Information Services The views expressed here are those of the author and do not reflect the official policy or position of Qualcomm Incorporated.

Pharma/Biotech. v. Technology: Patent Search & Analysis, PIUG Annual Meeting 2014

Embed Size (px)

Citation preview

Page 1: Pharma/Biotech. v. Technology: Patent Search & Analysis, PIUG Annual Meeting 2014

1

Pharma/biotech v. Technology Patent Search and Analysis

PIUG 2014 Annual Conference

Dilip P. PandyaManager, Research & Analysis, Qualcomm Library & Information Services

The views expressed here are those of the author and do not reflect the official policy or position of Qualcomm Incorporated.

Page 2: Pharma/Biotech. v. Technology: Patent Search & Analysis, PIUG Annual Meeting 2014

2

Born Mobile™

27+ years of driving the evolution of wireless communications

Making wireless more personal, affordable and accessible

World’s largest fabless semiconductor company

S&P 100/ S&P 500/ Fortune 500

The views expressed here are those of the author and do not reflect the official policy or position of Qualcomm Incorporated.

Page 3: Pharma/Biotech. v. Technology: Patent Search & Analysis, PIUG Annual Meeting 2014

3

AWARDS AND HONORS

Recognition for our technology innovations, business leadership and corporate culture.

FORTUNE and The World’s Most Admired Companies are registered trademarks of Time Inc. and are used under license.

The views expressed here are those of the author and do not reflect the official policy or position of Qualcomm Incorporated.

Page 4: Pharma/Biotech. v. Technology: Patent Search & Analysis, PIUG Annual Meeting 2014

4

Agenda

Pharma/biotech v. Technology Patent Search and Analysis: Similarities and Differences

Current challenges

Case study – mining a large patent portfolio

Completing the picture

About me…1

2

3

4

5

The views expressed here are those of the author and do not reflect the official policy or position of Qualcomm Incorporated.

Technology v. Pharma Patents comparison

Page 5: Pharma/Biotech. v. Technology: Patent Search & Analysis, PIUG Annual Meeting 2014

5

About me…

The views expressed here are those of the author and do not reflect the official policy or position of Qualcomm Incorporated.

What I used to do

− FTO, prior art searching, invalidity, supporting licensing & litigation

− Biosequence searching

− Chemical structure searching

What I do now – not a traditional patent searcher

− Patent landscaping of very large patent portfolios

− Lot of time devoted to developing iterative search strategies; analysis; custom macros; pivot tables and heat maps

− Often combine patent data with business and competitive intelligence information to create a more complete picture to address the question at hand, tapping into the expertise of other team members

Page 6: Pharma/Biotech. v. Technology: Patent Search & Analysis, PIUG Annual Meeting 2014

6

What types of output do I still generate?

The views expressed here are those of the author and do not reflect the official policy or position of Qualcomm Incorporated.

Country analysis : publication dates, priority dates, priority countries

Patent assignees vs. publication year /priority year /IPC /Derwent classes /CPC

Patent kind codes vs. country & year

Priority countries vs. earliest priority years

Reassignment analysis

Looking for patents in litigation, or subject to licensing / cross-licensing

So what do I have to do differently with Technology patent searching ?

Page 7: Pharma/Biotech. v. Technology: Patent Search & Analysis, PIUG Annual Meeting 2014

7

Technology v. Pharma patents comparison

Comparing US Patent grants for 2013: technology clearly leads over Pharma

The views expressed here are those of the author and do not reflect the official policy or position of Qualcomm Incorporated.

Page 8: Pharma/Biotech. v. Technology: Patent Search & Analysis, PIUG Annual Meeting 2014

8

Orange Book currently lists 3 patents for Lipitor –approved 1996

Orange Book currently lists 2 patents for Brintellix –approved 2013

By contrast, 802.11 WLAN standard lists over 190 patents!

FDA Approved drugs (Orange Book) v. technology patent comparison

Orange Book listed patents - drugs

Source: http://www.accessdata.fda.gov/scripts/cder/ob/default.cfm Source: http://standards.ieee.org/about/sasb/patcom/pat802_11.html

The views expressed here are those of the author and do not reflect the official policy or position of Qualcomm Incorporated.

802.11 listed patents

Page 9: Pharma/Biotech. v. Technology: Patent Search & Analysis, PIUG Annual Meeting 2014

9

“The whole is greater than the sum of its parts” (Aristotle)

Smartphone - it seems like the sum of the parts is greater than the whole

Patents provide protection for a large number of components that go into a Smartphone

Why so many technology patents?

Smartphone teardown example

The views expressed here are those of the author and do not reflect the official policy or position of Qualcomm Incorporated.

Page 10: Pharma/Biotech. v. Technology: Patent Search & Analysis, PIUG Annual Meeting 2014

10

Portfolio size is fundamental differenceSize of technology patent portfolios is the single biggest challenge to search & analysis

The views expressed here are those of the author and do not reflect the official policy or position of Qualcomm Incorporated.

Scope: ascertain the percentage of total patents filed annually in Korea, by technology company A

The total number of all patents is well over half a million!Large

technology

company A

Filing Year Korea Global Total Korea % of total

1992 4273 3105 7378 58

1993 3505 2686 6191 57

1994 4194 2801 6995 60

1995 18023 3826 21849 82

1996 24258 8355 32613 74

1997 31215 9849 41064 76

1998 19184 11601 30785 62

1999 15185 9949 25134 60

2000 11569 8796 20365 57

2001 13212 12089 25301 52

2002 16059 15841 31900 50

2003 21863 22635 44498 49

2004 31802 30166 61968 51

2005 32923 37009 69932 47

2006 25601 39662 65263 39

2007 19275 32982 52257 37

2008 13744 25126 38870 35

2009 12884 18285 31169 41

2010 12769 18020 30789 41

2011 3544 15387 18931 19

2012 226 2510 2736 8

665988

Page 11: Pharma/Biotech. v. Technology: Patent Search & Analysis, PIUG Annual Meeting 2014

11

Process steps in dealing with the large patent portfolios

The views expressed here are those of the author and do not reflect the official policy or position of Qualcomm Incorporated.

Exporting from source:

1.Take the large portfolio and search date ranges that result in <60K records.

2. Reduce the set by DWPI families

3. Export all the required fields using TDA format

Page 12: Pharma/Biotech. v. Technology: Patent Search & Analysis, PIUG Annual Meeting 2014

12

Importing into TDA

The views expressed here are those of the author and do not reflect the official policy or position of Qualcomm Incorporated.

Import individual sets of <60K patents into TDA using the import filter. − Only import Titles initially to minimize processing time as TDA uses local machine memory

Page 13: Pharma/Biotech. v. Technology: Patent Search & Analysis, PIUG Annual Meeting 2014

13

Combining data sets

The views expressed here are those of the author and do not reflect the official policy or position of Qualcomm Incorporated.

Combine date range sets using data fusion

Page 14: Pharma/Biotech. v. Technology: Patent Search & Analysis, PIUG Annual Meeting 2014

14

Import additional fields

The views expressed here are those of the author and do not reflect the official policy or position of Qualcomm Incorporated.

Import more fields into the fused set and analyze− Adding secondary or other fields

Page 15: Pharma/Biotech. v. Technology: Patent Search & Analysis, PIUG Annual Meeting 2014

15

Analysis

The views expressed here are those of the author and do not reflect the official policy or position of Qualcomm Incorporated.

Typical analysis done using co-occurrence matrix− Heatmaps, charting, relationships, etc.

Page 16: Pharma/Biotech. v. Technology: Patent Search & Analysis, PIUG Annual Meeting 2014

16

Completing the picture…

We often add other information to patent data to complete the competitive landscape

The views expressed here are those of the author and do not reflect the official policy or position of Qualcomm Incorporated.

Page 17: Pharma/Biotech. v. Technology: Patent Search & Analysis, PIUG Annual Meeting 2014

17

Current challenges, and how can the vendors & patent offices help?

The views expressed here are those of the author and do not reflect the official policy or position of Qualcomm Incorporated.

Assignee normalization, everyone’s favorite! TDA’s DWPI clean-up, thesaurus and list clean up functions do help somewhat but…

More timely reassignment information from the offices; identification of inventors reassigning to own companies by vendors

Download fields that match the search fields

Download fields already parsed e.g. assignee1, assignee2, inventor1, inventor2 etc.

Cloud based batch processing solutions e.g. TDA runs on local machine, and runs out of memory

Better seamless integration of patent data with other sources e.g. litigation, licensing, BI/CI, standards, SEC, VC, M&A etc.

Page 18: Pharma/Biotech. v. Technology: Patent Search & Analysis, PIUG Annual Meeting 2014

18

The views expressed here are those of the author and do not reflect the official policy or position of Qualcomm Incorporated.

Thank you !Questions?